Tiger Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-219,540
Closed -$32M 89
2017
Q3
$32M Sell
219,540
-63,700
-22% -$8.68M 5.79% 7
2017
Q2
$36.8M Sell
283,240
-3,100
-1% -$380K 7.23% 1
2017
Q1
$35.6M Sell
286,340
-12,400
-4% -$1.48M 6.72% 1
2016
Q4
$34.6M Sell
298,740
-70,200
-19% -$7.82M 6.27% 4
2016
Q3
$38.6M Sell
368,940
-10,200
-3% -$1.1M 9.11% 2
2016
Q2
$37.4M Buy
379,140
+150,300
+66% +$15.5M 12.06% 1
2016
Q1
$22.9M Buy
+228,840
New +$23.6M 5.74% 6

Other funds holding CELG

Tiger Management's CELG Position: Q4 2017 in Review

Tiger Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 219,540 shares — an estimated $32M sold.

Tiger Management first reported a position in CELG in Q1 2016 and held it in 7 quarters. The position peaked at $38.6M in Q3 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Tiger Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Tiger Management sold 219,540 Celgene Corp shares in Q4 2017, an estimated $32M.
  • Tiger Management first reported a position in Celgene Corp in Q1 2016 and held it in 7 quarters.
  • Tiger Management's Celgene Corp position peaked at $38.6M in Q3 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Tiger Management's 13F filing for Q4 2017, filed 14 Feb 2018.